Michael E. Nesheim

Affiliations: 
Queen's University, Canada, Kingston, Ontario, Canada 
Area:
Biochemistry
Google:
"Michael Nesheim"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Owczarek D, Undas A, Foley JH, et al. (2012) Activated thrombin activatable fibrinolysis inhibitor (TAFIa) is associated with inflammatory markers in inflammatory bowel diseases TAFIa level in patients with IBD. Journal of Crohn's & Colitis. 6: 13-20
Foley JH, Petersen KU, Rea CJ, et al. (2012) Solulin increases clot stability in whole blood from humans and dogs with hemophilia. Blood. 119: 3622-8
Kim PY, Kim PY, Taylor FB, et al. (2012) Thrombin-activatable fibrinolysis inhibitor is activated in vivo in a baboon model of Escherichia coli induced sepsis. Journal of Thrombosis and Thrombolysis. 33: 412-5
Foley JH, Nesheim ME, Rivard GE, et al. (2011) Thrombin activatable fibrinolysis inhibitor activation and bleeding in haemophilia A. Haemophilia : the Official Journal of the World Federation of Hemophilia. 18: e316-22
Song JJ, Hwang I, Cho KH, et al. (2011) Plasma carboxypeptidase B downregulates inflammatory responses in autoimmune arthritis. The Journal of Clinical Investigation. 121: 3517-27
Foley JH, Cook PF, Nesheim ME. (2011) Kinetics of activated thrombin-activatable fibrinolysis inhibitor (TAFIa)-catalyzed cleavage of C-terminal lysine residues of fibrin degradation products and removal of plasminogen-binding sites. The Journal of Biological Chemistry. 286: 19280-6
Kim PY, Nesheim ME. (2010) Down regulation of prothrombinase by activated protein C during prothrombin activation. Thrombosis and Haemostasis. 104: 61-70
Hirbawi J, Kim PY, Nesheim ME, et al. (2010) The Role of Amino Acids 700–701 of the Factor Va Heavy Chain During Prothrombin Activation by Factor Xa Blood. 116: 2203-2203
Kim PY, Manuel R, Nesheim ME. (2009) Differences in prethrombin-1 activation with human or bovine factor Va can be attributed to the heavy chain. Thrombosis and Haemostasis. 102: 623-33
Willemse JL, Heylen E, Nesheim ME, et al. (2009) Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy? Journal of Thrombosis and Haemostasis : Jth. 7: 1962-71
See more...